Demographics (1)
- SEX - Self-reported sex (phv00421137.v1.p1)
Other (19)
- ANALYTE_TYPE - Analyte type (phv00421145.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00421144.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00421132.v1.p1)
- GEO_ACCESSION - GEO accession ID (phv00421142.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00421147.v1.p1)
- IS_TUMOR - Tumor status (phv00421146.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00421148.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00421149.v1.p1)
- RESPONSE - Status of the subject for pathologic complete response to neoadjuvant treatment (phv00421136.v1.p1)
- SAMPLE_ID - Sample ID (phv00421143.v1.p1)
- SAMPLE_ID - Sample ID (phv00421134.v1.p1)
- SAMPLE_ID - Sample ID (phv00421141.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00421150.v1.p1)
- SUBJECT_ID - Subject ID (phv00421135.v1.p1)
- SUBJECT_ID - Subject ID (phv00421131.v1.p1)
- SUBJECT_ID - Subject ID (phv00421133.v1.p1)
- TUMOR_HR_STATUS - Hormone receptor status of subject's breast tumor (phv00421138.v1.p1)
- TUMOR_TREATMENT - Treatment subject received (phv00421140.v1.p1)
- TUMOR_TYPE - Clinical phenotypic subtype of breast tumor (phv00421139.v1.p1)